Tetrem Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-434,505
Closed -$57.5M 25
2017
Q2
$57.5M Sell
434,505
-99,125
-19% -$12.6M 2.51% 15
2017
Q1
$66.5M Sell
533,630
-36,216
-6% -$4.33M 2.74% 11
2016
Q4
$65.7M Sell
569,846
-97,686
-15% -$11.3M 2.63% 9
2016
Q3
$78.9M Buy
667,532
+50,548
+8% +$6.13M 2.96% 7
2016
Q2
$74.8M Sell
616,984
-6,577
-1% -$747K 2.9% 8
2016
Q1
$67.5M Sell
623,561
-2,390
-0.4% -$247K 2.65% 9
2015
Q4
$64.3M Sell
625,951
-47,859
-7% -$4.81M 2.56% 9
2015
Q3
$62.9M Sell
673,810
-24,804
-4% -$2.4M 2.14% 12
2015
Q2
$68.1M Buy
698,614
+61,326
+10% +$6.14M 2.09% 13
2015
Q1
$64.1M Sell
637,288
-180,002
-22% -$18.3M 1.95% 12
2014
Q4
$85.5M Sell
817,290
-72,267
-8% -$7.62M 2.41% 9
2014
Q3
$94.8M Buy
889,557
+60,209
+7% +$6.24M 2.52% 10
2014
Q2
$92.6M Sell
829,348
-2,202
-0.3% -$223K 2.28% 10
2014
Q1
$81.7M Buy
831,550
+81,153
+11% +$7.52M 2.22% 12
2013
Q4
$68.7M Sell
750,397
-28,100
-4% -$2.59M 1.87% 16
2013
Q3
$67.5M Sell
778,497
-59,593
-7% -$5.35M 2.05% 12
2013
Q2
$72M Buy
+838,090
New +$71.1M 2.41% 9

Other funds holding JNJ

Tetrem Capital Management's JNJ Position: Q3 2017 in Review

Tetrem Capital Management sold out of Johnson & Johnson (JNJ) in Q3 2017, closing a stake of 434,505 shares — an estimated $57.5M sold.

Tetrem Capital Management first reported a position in JNJ in Q2 2013 and held it in 17 quarters. The position peaked at $94.8M in Q3 2014. 2,356 funds tracked by Wall St. Rank hold JNJ as of Q3 2017.

  • Tetrem Capital Management reported no remaining Johnson & Johnson position as of Q3 2017 after selling out during the quarter.
  • Tetrem Capital Management sold 434,505 Johnson & Johnson shares in Q3 2017, an estimated $57.5M.
  • Tetrem Capital Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 17 quarters.
  • Tetrem Capital Management's Johnson & Johnson position peaked at $94.8M in Q3 2014.
  • 2,356 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2017.

Based on Tetrem Capital Management's 13F filing for Q3 2017.